SWK
61
5
CRM
65
6
ALLE
44
7
DVN
18
2
NSC
57
7
MLM
51
3
KLAC
43
4
IPG
53
4
DHI
44
-4
RRC
59
-4
FOXA
59
4
GRMN
64
2
JNJ
44
3
ORCL
67
2
RL
68
3
O
22
2
CVS
50
2
ADI
47
2
AKAM
50
7
AVY
50
2
SWK
61
5
CRM
65
6
ALLE
44
7
DVN
18
2
NSC
57
7
MLM
51
3
KLAC
43
4
IPG
53
4
DHI
44
-4
RRC
59
-4
FOXA
59
4
GRMN
64
2
JNJ
44
3
ORCL
67
2
RL
68
3
O
22
2
CVS
50
2
ADI
47
2
AKAM
50
7
AVY
50
2
Financhill
Back

Janux Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

JANX
Janux Therapeutics

Last Price:
50.47
Seasonality Move:
7.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Janux Therapeutics Price Quote

$50.47
+3.97 (+8.54%)
(Updated: November 22, 2024 at 5:55 PM ET)

Janux Therapeutics Key Stats

Sell
34
Janux Therapeutics (JANX) is a Sell
Day range:
$45.95 - $49.78
52-week range:
$7.79 - $65.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
182.49
P/B ratio:
3.72%
Volume:
786K
Avg. volume:
670.2K
1-year change:
434.48%
Market cap:
$2.4B
Revenue:
$8.1M
EPS:
$-1.16

How Much Does Janux Therapeutics Make?

Is Janux Therapeutics Growing As A Company?

  • What Is Janux Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.83%
  • What Is Janux Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Janux Therapeutics Stock Price Performance

What Is Janux Therapeutics 52-Week High & Low?

Janux Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Janux Therapeutics?

Is Janux Therapeutics Cash Flow Positive?

  • What Is JANX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$37M
  • What Is Janux Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $327.4M
  • What Is Janux Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$280.8M

Janux Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    JANX return on invested capital is -11.37%
  • What Is Janux Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -10.65%
  • What Is JANX Return On Equity?
    ROE is a measure of profitability and is -11.37%

Janux Therapeutics Earnings Date & Stock Price

Janux Therapeutics Competitors

  • Who Are Janux Therapeutics's Competitors?
    Below is a list of companies who compete with Janux Therapeutics or are related in some way:
    • Dynavax Technologies Corp (DVAX)
    • iBio Inc (IBIO)
    • Krystal Biotech Inc (KRYS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Janux Therapeutics Dividend Yield

Janux Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -42.99%
Revenue: -82.56% -73.32%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 66.18
Upside from Last Price: 42.33%

Major Shareholders

  • How many JANX shares are owned by institutional investors?
    86.4M JANX shares are owned by institutional investors
  • How many JANX shares are owned by insiders?
    926.7K JANX shares are owned by insiders